Abstract|Topic: 7 - Neuromuscular disorders| Volume 333, SUPPLEMENT 1, e471, October 15, 2013

Taurine ameliorates mitochondrial dysfunction and prevents stroke-like episodes in patients with MELAS

      In 1966, Francis Crick predicted that the first anticodon (“wobble”) nucleotide recognizes the third codon nucleotide through non-canonical Watson–Crick geometry. To date, post-transcriptional modifications in tRNAs are thought to play critical roles in deciphering the genetic code. In MELAS patients harbouring the A3243G-mutant mitochondrial DNA, post-transcriptional taurine modification at the wobble nucleotide is deficient in the mutant mitochondrial (mt) tRNALeu(UUR). Here, we show that addition of taurine to culture media ameliorated reduced oxygen consumption, decreased mitochondrial membrane potential, and increased oxidative stress in MELAS patient-derived pathogenic cells. Moreover, high dose oral administration of taurine (0.25 g/kg/day) completely prevented stroke-like episodes in two MELAS patients for more than nine years. These findings provide a new insight into our understanding of MELAS as putative RNA-modification disorders that lack the wobble taurine modification. The oral administration of taurine may be an effective therapy for MELAS.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect